Skip to main content
SpringerLink
Log in

Transgenic Hepatitis B Virus Mouse Model in the Study of Chemotherapy

  • Protocol
Hepatitis B and D Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 96))

Abstract

Much of the knowledge about hepatitis B virus (HBV) has been obtained from the infection of natural hosts with nonhuman hepatitis viruses that possess similar characteristics to HBV, such as in the duck and woodchuck. Transgenic mouse models have also been valuable in recent years for studying the biology of the virus (1–7) and for evaluating antiviral compounds (3,8–11). The development of the transgenic mouse model carrying the infectious HBV genome has been motivated in part by the expense and minimal availability of the HBV chimpanzee model, and the absence of more convenient, small non-primate animal models that can be infected with HBV.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Guidotti, L.G., Matzke, B., Schaller, H., and Chisari, F.V (1995) High-level hepatitis B virus replication in transgenic mice. J. Virol. 69, 6158–6169.

    PubMed  CAS  Google Scholar 

  2. Wirth, S., Guidotti, L.G., Ando, K., Schlicht, H.-J., and Chisari, F.V. (1995) Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J. Immunol. 154, 2504–2515.

    PubMed  CAS  Google Scholar 

  3. Cavanaugh, V.J., Guidotti, L. G., and Chisari, F. V. (1997) Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 71, 3236–3243.

    PubMed  CAS  Google Scholar 

  4. Guidotti, L. G., Matzke, B., and Chisari, F.V. (1997) Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice. J. Virol. 71, 4804–4808.

    PubMed  CAS  Google Scholar 

  5. Larkin, J., Clayton, M., Sun, B., et al. (1999) Hepatitis B virus transgenic mouse model of chronic liver disease. Nat. Med. 5, 907–912.

    Article  PubMed  CAS  Google Scholar 

  6. Raney, A.K., Eggers, C. M., Kline, E. F., et al. (2001) Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J. Virol. 75, 2900–2911.

    Article  PubMed  CAS  Google Scholar 

  7. Sette, A.D., Oseroff, C., Sidney, J., (2001) Overcoming T cell tolerance to the hepaititis B virus surface antigen in hepatitis B virus-transgenic mice. J. Immunol. 166, 1389–1397.

    PubMed  CAS  Google Scholar 

  8. Kajino, K., Kamiya, N., Yayasa, S., Takahara, T., Sakurai, J., Yamamura, K.-I., and Hino, O. (1997) Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy. Biochem. Biophys. Res. Commun. 241, 43–48.

    Article  PubMed  CAS  Google Scholar 

  9. Marion, P.L., Salazar, F. H., Liittschwager, K., and Bordier, B.B. (1998) Transgenic mouse lineages with potential for testing antivirals targeting hepatitis B virus. ICAAC Session 201-H, H–150.

    Google Scholar 

  10. Morrey, J.D., Korba, B.E., and Sidwell, R.W. (1999) Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antiviral Ther. 3(Suppl 3), 59–68.

    Google Scholar 

  11. Morrey, J. D., Bailey, K. W., Korba, B.E., and Sidwell, R.W. (1999) Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral Res. 42, 97–108.

    Article  PubMed  CAS  Google Scholar 

  12. Perfumo, S., Amicone, I., Colloca, S., Giorgio, M., Pozzi, I., and Tripodi, M. (1992) Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice. J. Virol. 66, 6819–6823.

    PubMed  CAS  Google Scholar 

  13. Araki, K., Miyazaki, J., Hino, O., et al. (1989) Expression and replication of hepatitis B virus genome in transgenic mice. Proc. Natl. Acad. Sci. USA 86, 207–211.

    Article  PubMed  CAS  Google Scholar 

  14. Gilles, P.N., Fey, G., and Chisari, F. V. (1992) Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66, 3955–3960.

    PubMed  CAS  Google Scholar 

  15. Julander, J. G., Sidwell, R.W., and Morrey, J.D. (2002). Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. Antiviral Res. 55, 27–40.

    Article  PubMed  CAS  Google Scholar 

  16. Guidotti, L. G., Guilhot, S., and Chisari, F.V. (1994) Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and-independent pathways. J. Virol. 68, 1265–1270.

    PubMed  CAS  Google Scholar 

  17. Guilhot, S., Guidotti, L. G., and Chisari, F. V. (1993) Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J. Virol. 67, 7444–7449.

    PubMed  CAS  Google Scholar 

  18. Nagahata, T., Araki, K., Yamamura, K.-I., and Matsubara, K. (1992) Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model. Antimicrob. Agents Chemother. 36, 2042–2045.

    CAS  Google Scholar 

  19. Petersen, J., Dandri, M., Gupta, S., and Rogler, C.E. (1998) Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 95, 310–315.

    Article  PubMed  CAS  Google Scholar 

  20. Elmore, L.W., Hancock, A.R., Chang, S.-F., et al. (1997) Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc. Natl. Acad. Sci. USA 94, 14707–14712.

    Article  PubMed  CAS  Google Scholar 

  21. Kawashima, T. (1964) The lymph system in mice. Jpn. J. Vet. Res. 12, 69–81.

    Google Scholar 

  22. Mehta, A., Lu, X., Block, T.M., Blumberg, B.S., and Dwek, R.A. (1997) Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc. Natl. Acad. Sci. USA 94, 1822–1827.

    Article  PubMed  CAS  Google Scholar 

  23. Baginski, I., Ferrie, A., Watson, R., and Mack, D. (1990) Detection of hepatitis B virus, in PCR Protocols: A Guide to Methods and Applications (Innis, M.A., Gelfand, D.H., Sninsky, J. J., and White, T. J., eds.), Hartcourt Brace-Jovanovich Publishers, San Diego.

    Google Scholar 

  24. Budelier, K. and Schorr, J. (1995) Preparation and analysis of DNA, in Current Protocols in Molecular Biology, Vol. 1 (Ausubel, F.M., Brent, R., Kingston, R. E., et al., eds.), John Wiley & Sons, New York, pp. 2.9.7–2.9.8.

    Google Scholar 

  25. Cate, C. (1969) A successful method for exsanguinating unanesthetized mice. Lab. Anim. Care 19, 256–258.

    PubMed  CAS  Google Scholar 

  26. Greenberg, M.E. (1995) Preparation and analysis of RNA, in Current Protocols in Molecular Biology, Vol. 1 (Ausubel, F., Brent, R., Kingston, R. E., et al. eds.), John Wiley & Sons, New York, pp. 4.9.1–4.9.8.

    Google Scholar 

  27. Krajden, M., Minor, J.M., Rifkin, O., and Comanor, L. (1999) Effect of multiple freeze-thaw cycles on hepatitis B virus DNA and hepatitis C virus RNA quantification as measured with branched-DNA technology. J. Clin. Microbiol. 37, 1683–1686.

    PubMed  CAS  Google Scholar 

  28. NIH (1994) Appendix B-II-D. Class 2 viral, rickettsial, and chlamydial agents, in Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines). U.S. Government Printing Office, Washington, D.C.

    Google Scholar 

  29. Richmond, J.Y. and McKenney, R.W., eds. (1993) Biosafety in Microbiological and Biomedical Laboratories U.S. Government Printing Office, Washington, D.C.

    Google Scholar 

  30. Brown, T. (1994) Analysis of DNA sequences by blotting and hybridization, in Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R., et al., eds.), John Wiley & Sons, New York, pp. 2.9.1–2.10.16.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT

    John D. Morrey

Authors
  1. John D. Morrey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ribapharm Inc., Costa Mesa, CA

    Robert K. Hamatake PhD  & Johnson Y. N. Lau MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc.

About this protocol

Cite this protocol

Morrey, J.D. (2004). Transgenic Hepatitis B Virus Mouse Model in the Study of Chemotherapy. In: Hamatake, R.K., Lau, J.Y.N. (eds) Hepatitis B and D Protocols. Methods in Molecular Medicine™, vol 96. Humana Press. https://doi.org/10.1385/1-59259-670-3:239

Download citation

  • DOI: https://doi.org/10.1385/1-59259-670-3:239

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-108-0

  • Online ISBN: 978-1-59259-670-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation